Product Information

GABAPENTIN 600 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0654 per EA under NDC 76282070605. Its NADAC has been published 257 times since Dec 22, 2021.

FDA first approved this application on Oct 1, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 600 MG TABLET

Gabapentin
$0.0654per EA

Strength

600 mg/1

NDC

76282070605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214957

FDA Approved

10/1/2021

TE Code

AB1

On Market Since

10/1/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 600 MG TABLET has been published 257 times since Dec 22, 2021, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0654 per EA
All-time high$0.1086 (Jan 10, 2024)
All-time low$0.0602 (Nov 20, 2024)
52-week high$0.0703
52-week low$0.0638
Median price$0.0896
Average price$0.0848
Largest weekly change-36.7% (Nov 20, 2024)
Weeks tracked257
Tracking sinceDec 22, 2021

Price History

1W

+2.3%

1M

+2.3%

3M

+2.6%

6M

-4.1%

1Y

-6.9%

3Y

-32.9%

5Y

N/A

All

-23.5%

Generic Alternatives

The matcher finds 22 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 600 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0654 per EA (NDC 76282070605), effective Nov 18, 2026.

How has the price of GABAPENTIN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 600 MG TABLET has declined 23.5%. It has been tracked across 257 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 600 MG TABLET?

Since Dec 22, 2021, the NADAC for GABAPENTIN 600 MG TABLET has ranged from a low of $0.0602 (Nov 20, 2024) to a high of $0.1086 (Jan 10, 2024), with a median of $0.0896 per EA.

Are there cheaper alternatives to GABAPENTIN 600 MG TABLET?

22 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 600 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 600 MG TABLET?

GABAPENTIN 600 MG TABLET (NDC 76282070605) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.